Making Science Group Sa · BME:MAKS

Making Science Group Sa — Foro MEDCAP 2020

22 slides from Making Science Group Sa's conference presentation, May 27, 2020

  1. Slide 1: Otra información relevante

    Madrid, 26 de Mayo de 2020 MAKING SCIENCE GROUP, S.A. (la "Sociedad") en virtud de lo previsto en el artículo 17 del Reglamento (UE) nº 596/2014 sobre abuso de mercado y en el artículo 228 del texto refundido de la Ley de Mercado de Valores, aprobado por el Real Decreto Legislativo 4/2015, de 23 de

  2. Slide 2: Discovery Meeting: Foro MEDCAP 2020

    José Antonio Martínez Aguilar Making Science CEO Making Science Discovery Meeting: Foro MEDCAP 2020 May, 27th 2020

  3. Slide 3: Disclaimer

    Disclaimer This document and the conference-call webcast (including the Q&A session) may contain forward-looking statements and information (hereinafter, the “information”) relating to MAKING SCIENCE GROUP, S.A (hereinafter “Making Science” or the “Company”). This information may include financial f

  4. Slide 4: About Making Science

    About Making Science Madrid, Barcelona +250 + 140 Customers in 2019 Paris, Milan, Dublin, Consultants Public Company Lisbon and Mexico + 50 million in revenue in +80 Software Developers and Focused in eCommerce and EY Entrepreneur of Data Scientist High Growth 2020 (USD) Digital the Year High Transf

  5. Slide 5: Who we are: The Creation of the Group

    Who we are: The Creation of the Group €47.000 K (e) 280 €36.000 K 230 €19.000 K 180 €13.000 K €6.000 K (e) 150 Revenue 85 Employees 2016 2017 2018 2019 2020 4

  6. Slide 6: What we do: Differential Value Proposition of Making Science

    What we do: Differential Value Proposition of Making Science Team and 360 Management Capabilities Paid Media Brand Content Generation of campaign Analytics, CRO, Machine Identity, Platform UX UI Platform Develop & Production, SEO optimization feed for Dashboarding Learning, AI Infrastructure managem

  7. Slide 7: Making Science ecosystem

    Making Science ecosystem Development Omnichannel Systems and Advertising Infrastructures Data eCommerce Digital Strategy CRO SEO Technology Adtech CMS UX/UI Social Martech Brand & Content 6

  8. Slide 8: Differential Value Proposition

    Differential Value Proposition Based on our technological partnerships And in our own Technology Data Quality Data quality assurance Artificial intelligence. Valuation of cookies, leads and customization Feeds management to adapt to Google Shopping. Comparison Shopping Site Ecommerce Framework: spee

  9. Slide 9: Our customers

    © making science Our customers 2Sareb wars Conte fngea’e waECHE «> Santander Carrefour @ IFEMA Feria de Madrid Di ceca IBERDROLA NH HOTELS pullmantur = sts ENGEL&VOLKERS Neinor Liber__bank elas PSA Wy) GROUPE mazpa je CZ ell eDreams R l U HOTELS & RESORTS, e AT) < O id Reinventing AY Higher Educatio

  10. Slide 10: In which segments we operate: We work in four high growth markets

    In which segments we operate: We work in four high growth markets Digital Advertising Cloud Digital Advertising e-Commerce Business Analytics

  11. Slide 11: What is our aspiration?

    What is our aspiration? Our aspiration: “We want to be present in the Top 20 advertising markets in 5 years” We are here Source: Statista

  12. Slide 12: Highlights 2019 Results

    Highlights 2019 Results ● Acceleration of growth of consolidated proforma revenue (€35,531K) and EBITDA (€2,505K) ● Continued investment in technology and innovation ● Acquisition of mCentric and Probability Domain to finish the consolidation of the group ● Successful IPO on MAB in Spain ● Accelerati

  13. Slide 13: DIIM Consolidated Proforma Figures

    DIIM Consolidated Proforma Figures 12

  14. Slide 14: Revenue

    Revenue -Our consolidated proforma revenue has been growing over the last three years due to new customer acquisition and more revenue per customer -The media and technology revenue item continues to grow and will continue to grow in the future -Our “managed business” is three times in size our reve

  15. Slide 15: EBITDA

    EBITDA -Solid consolidated proforma EBITDA growth over the last three years in an scenario of investment in people to grow the business -We have managed to increase our revenue per head in an inflationary talent environment -Our objective is to try to keep the EBITDA/Gross Margin ratio around 20% 14

  16. Slide 16: Debt (Consolidated Proforma Figures)

    Debt (Consolidated Proforma Figures) Miles de euros 2019 2018 Deuda Neta 1.247 1.643 Efectivo y otros activos líquidos equivalentes -7.560 -5.218 Inversiones financieras a corto plazo -552 -665 Deudas a largo plazo 2.360 2.290 Deudas con empresas del grupo y asociadas a largo plazo 418 1.116 Deudas

  17. Slide 17: Capex (R&D)

    Capex (R&D) Thousand Euros 16

  18. Slide 18: Q1 2020 Highlights

    Q12020 Highlights ● Making Science has maintained its momentum during Q1 with consolidated revenues of €12.179K and consolidated EBITDA of €849K ● We have signed new contracts in México and Italy ● COVID-19 created turbulences in the second half of March ● We have managed to maintain service with al

  19. Slide 19: Share Price Evolution

    Share Price Evolution The share price peaked at €6.9 and then fell to €3.26 accelerated by COVID-19 and went up sharply since the beginning of April and now is getting stable around €5.5 18

  20. Slide 20: Our Future and Plans

    Our Future and Plans ● We think 2020 is going to be a challenging year with lots of uncertainties ● We think our focus in Digital Transformation and eCommerce brings us opportunities and future growth ● Our objective is to continue our growth in Spain and Internationally ● We think the market and th

  21. Slide 21: Thank you!

    Thank you! makingscience.com 20

  22. Slide 22: Making Science Q&A

    Making Science Q&A

Making Science Group — Foro MEDCAP 2020 on 6ix